Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 3, 1999, Pages 305-309

  Hagel, C ^a   Krog, B ^a   Laas, R ^a   Stavrou, D K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Ki 67; Oligodendroglioma; p53; Prognosis

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CANCER GRADING; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GENES, P53; GERMANY; GLIOBLASTOMA; HUMANS; KI-67 ANTIGEN; LIFE TABLES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGODENDROGLIOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032751984     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Zhang W., Hu G., Esley E., Hester J., Deisseroth A.: Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells. Oncogene 7: 1645-1647, 1992.
2. Alderson L.M., Castleberg R.L., Harsh IV G.R., Louis D.N., Henson J.W.: Human gliomas with wild-type p53 express bcl-2. Cancer Res. 55: 999-1001, 1995.
3. Bögler O., Su Huang H.-J., Kleihues P., Cavenee W.K.: The p53 gene and its role in human brain tumors. Glia 15: 308-327, 1995.
4. Kros J.M., Godschalk J.J.C.J., Krishnadath K.K., van Eden C.G.: Expression of p53 in oligodendrogliomas. J. Pathol. 171: 285-290, 1993.
5. Pavelic J., Hlavka V., Poljak M., Pavelic K.: p53 immunoreactivity in oligodendrogliomas. J. Neuro-Oncol. 22: 1-6, 1994.
6. Hagel C., Laking G., Laas R. et al.: Demonstration of p53 protein and TP53 gene mutations in oligodendrogliomas. Eur. J. Cancer 32A: 2242-2248, 1996.
7. Cattoretti G., Becker M.H., Key G. et al.: Monoclonal antibodies against parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol. 168: 357-363, 1992.
8. Hagel C., Schwarz P., Laas R., Stavrou D.K.: Comparison of four proliferation markers and their significance for evaluation of tumor dignity in intracranial tumors. Int. J. Oncol. 7: 107-113, 1995.
9. Ellison D.W., Steart P.V., Bateman A.C., Pickering R.M., Palmer J.D., Weller R.O.: Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies. J. Neurol. Neurosurg. Psychiatry 59: 413-419, 1995.
10. Smith M.T., Ludwig C.L., Godfrey A.D., Armbrustmacher V.W.: Grading of oligodendrogliomas. Cancer 52: 2107-2114, 1983.
11. Cunningham J.M., Kimmel D.W., Scheithauer B.W., O'Fallon J.R., Novotny P.J., Jenkins R.B.: Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value. J. Neurosurg. 86: 121-130, 1997.
12. Louis D.N., von Deimling A., Chung R.Y. et al.: Comparative study of p53 gene and protein alterations in human astrocytic tumors. J. Neuropathol. Exp. Neurol. 52: 31-38, 1993.
13. Rasheed B.K.A., McLendon R.E., Herndon J.E. et al.: Alterations of the TP53gene in human gliomas. Cancer Res. 54: 1324-1330, 1994.
14. Soini Y., Niemelä A., Kamel D. et al.: p53 immunohistochemical positivity as prognostic marker in intracranial tumours. APMIS 102: 786-792, 1994.
15. Rieger L., Weller M., Bornemann A., Schabet M., Dichgans J., Meyermann R.: BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study. J. Neurol. Sci. 155: 68-75, 1998.
16. Newcomb E.W., Bhalla S.K., Parrish C.L., Hayes R.L., Cohen H., Miller D.C.: bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Acta Neuropathol. 94:369-375, 1997.
17. Sato K., Schauble B., Kleihues P., Ohgaki H.: Infrequent alterations of the p 15, p 16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors. Int. J. Cancer 66:305-308, 1996.
18. Maintz D., Fiedler K., Koopmann J. et al.: Molecular genetic evidence for subtypes of oligoastrocytomas. J. Neuropathol. Exp. Neurol. 56:1098-1104, 1997.